Lifestyle changes
Take breaks from sustained near work, use comfortable lighting, and keep prescriptions and eye checks up to date. Protect your eyes appropriately outdoors and during activities with an injury risk.
Vision Support
Vision support focuses on the nutritional needs of the eyes and the comfort of using them throughout the day. Clear sight depends on several specialized tissues working together, while visual tasks place different demands on focus and the eye surface. Your priority may be everyday comfort, retinal nutrition, or maintaining normal vision over time. Different nutrients have distinct roles in this picture. Certain carotenoids form part of the eye’s pigment system, vitamin A contributes to normal visual processes, and DHA is a component of retinal tissue. Targeted formulations bring together selected ingredients according to the aspect of eye nutrition they are intended to support. The most useful approach reflects your circumstances and regular eye care. Comfort during screen work, the demands of changing light, and longer-term nutritional priorities are separate considerations. Keeping the purpose clear helps you choose suitable support and place everyday observations alongside the information provided by professional eye assessments.
Warnings
- Sudden vision changes need prompt care: Sudden loss of vision, new flashes, or other abrupt visual changes need prompt assessment. Do not wait for an eye supplement to work or assume the symptoms reflect a vitamin shortage.
- Check the exact eye formulation: Beta-carotene-containing eye supplements may be unsuitable for current or former smokers. AREDS2 suitability also depends on the stage of macular degeneration. Choose with an eye-care professional.
- Check medicine interactions: Ask a pharmacist or clinician to review your exact products alongside your medicines. The ingredient, amount, and treatment determine which combinations are suitable.
- Avoid overlapping high doses: Count nutrients from multivitamins, individual supplements, and fortified products together. Keep the combined amounts within appropriate limits for your circumstances.
Ingredient overview
Goal guidance
Diet changes
Include leafy vegetables, other colorful plants, and suitable sources of dietary fats. Choose targeted eye nutrients according to your usual intake and eye-care needs.
Who this is for
Adults interested in eye nutrition, visual comfort, and maintaining normal vision through everyday and age-related demands.
Who should be careful
Discuss eye formulations with an eye-care professional, especially with a diagnosed condition or smoking history. Beta-carotene may be unsuitable for current or former smokers; sudden vision changes need prompt assessment.
Expected timeline
Comfort during visual tasks can be followed day to day, while nutritional support is a longer-term routine. Use regular eye assessments to track changes that are not easy to judge yourself.
Common mistakes
Relying on supplements while overlooking screen breaks, lighting, or an outdated prescription can leave practical needs unmet. Match nutritional support to your situation and keep eye care consistent.
Ingredients
carotenoids Other Nutrients
Impact
Highest effect
Typical dose10–24 mg / day
Lutein and Zeaxanthin are the only carotenoids that accumulate in the macula, forming the macular pigment. This pigment acts like internal sunglasses, filtering high-energy blue light and neutralizing free radicals, which is critical for slowing the progression of age-related macular degeneration (AMD) as shown in the AREDS2 clinical trials.
- Focuses on
- Most relevant for
- Individuals interested in eye health nutrients that require more direct clinical evidence to confirm specific vision benefits.
Potential benefits
- Macular Pigment Support.Unconfirmed. Carotenoids are contextually associated with maintaining macular pigment, but the specific benefit for vision support is unproven in this context.
- Blue Light Filtering.Unconfirmed. It is suggested that certain carotenoids filter high-energy blue light, though this effect is not confirmed by supplied research.
- Oxidative Stress Reduction.Unconfirmed. These nutrients may act as antioxidants in the eye, but their role in improving vision outcomes is currently unconfirmed.
Limitations
- Missing Research.No linked clinical studies or research summaries were provided to establish a direct benefit for vision support.
- Unproven Efficacy.The impact of these carotenoids on long-term retinal health and AMD progression remains unverified without supporting data.
Study evidence
No published studies for this goal yet.
Vitamin C Vitamins
Impact
Highest effect
Typical dose250–1000 mg / day
The eye's lens and aqueous humor have very high concentrations of Vitamin C to combat oxidative stress from UV light. Studies, including the AREDS trials, show that Vitamin C, as part of an antioxidant cocktail, can slow the progression of AMD and may reduce the risk of cataract formation.
- Focuses on
- Most relevant for
- Most relevant for aging adults and individuals post-cataract surgery seeking to maintain eye health through antioxidant support.
Potential benefits
- Post-Surgical Recovery Support.Daily oral supplementation may help reduce postoperative astigmatism and improve patient comfort following cataract surgery.
- Support for AMD Progression.Unconfirmed. High dietary intake of Vitamin C is associated with a decreased risk of early age-related macular degeneration (AMD) progressing to late-stage disease.
- Cataract Risk Reduction.Unconfirmed. Long-term intake or high serum levels of Vitamin C are associated with a lower likelihood of developing age-related cataracts in some populations.
Limitations
- No Prevention of AMD.High-certainty evidence indicates that Vitamin C supplementation does not prevent the initial development of age-related macular degeneration in healthy individuals.
- Mixed Cataract Findings.Clinical results are inconsistent, with some large-scale studies showing no significant benefit for preventing cataracts or reducing the need for extraction.
- Dependency on Other Nutrients.Evidence for slowing eye disease often involves Vitamin C as part of a multi-nutrient antioxidant formula, making its independent effect difficult to isolate.
Things to consider
While generally regarded as safe, clear evidence of benefit for preventing the onset of eye disease is lacking, and some multivitamin trials have reported minor side effects like skin rashes.
Study evidence
24 studiesHigher vitamin C intake or levels are associated with better eye-health outcomes in some studies, but results are inconsistent. Controlled evidence does not show that vitamin C supplements prevent age-related macular degeneration, and broader claims about preserving vision or preventing cataracts remain unproven.
Vitamin E Vitamins
Impact
Highest effect
Typical dose200–400 IU / day
Vitamin E works synergistically with Vitamin C and other antioxidants to protect the delicate fatty acids in the retina from free radical damage. Its inclusion in the AREDS/AREDS2 formula highlights its clinical efficacy in slowing the progression of age-related macular degeneration.
- Focuses on
- Most relevant for
- Individuals with existing intermediate or advanced macular degeneration using specific multi-nutrient antioxidant formulas.
Potential benefits
- AMD Progression Support.Unconfirmed. Vitamin E is a component of clinical formulas used to slow the progression of advanced age-related macular degeneration, though its independent benefit for this goal is unproven as it was studied in combination with other antioxidants.
- Dietary Health Associations.Unconfirmed. While higher dietary intake of vitamin E is associated with lower risks of cataracts in population studies, the benefit of vitamin E supplements for preventing eye disease is unproven as clinical trials have shown no effect.
Limitations
- Ineffective for Prevention.Extensive randomized controlled trials have consistently shown that vitamin E supplements alone do not prevent the initial development of cataracts or age-related macular degeneration.
- Adverse Effects in Retinitis Pigmentosa.Clinical research indicates that supplemental vitamin E may accelerate the decline of retinal function in individuals with retinitis pigmentosa.
- Potential Late-Stage Risks.Some evidence suggests that high-dose vitamin E intake may paradoxically be associated with an increased risk of developing late-stage macular degeneration and hemorrhagic stroke.
Things to consider
Avoid use for vision support if you have retinitis pigmentosa. High doses may increase the risk of certain types of stroke or interact with blood-thinning medications.
Study evidence
35 studiesVitamin E alone has not prevented age-related macular degeneration or cataracts in randomized trials. Combination eye supplements can slow progression in selected people with existing macular degeneration, but their benefit cannot be assigned to vitamin E alone; harm has been reported in retinitis pigmentosa.
Zinc Minerals
Impact
Highest effect
Typical dose25–80 mg / day
Zinc is highly concentrated in the retina and is a critical cofactor for many enzymes involved in eye function. It plays a key role in transporting Vitamin A from the liver to the retina, which is necessary for producing melanin, a pigment that protects the eye. It is a cornerstone of the AREDS/AREDS2 formula for AMD.
- Focuses on
- Most relevant for
- Individuals with intermediate age-related macular degeneration or those at high risk for advanced vision loss.
Potential benefits
- Slows AMD Progression.Strong evidence from major clinical trials indicates that zinc, especially in specific antioxidant formulations, significantly reduces the risk of intermediate macular degeneration progressing to advanced stages.
- Reduces Vision Loss Risk.Zinc supplementation is associated with a lower likelihood of losing significant visual acuity in people who already show signs of macular damage.
- Supports Dark Adaptation.In individuals with nutritional deficiencies, zinc can help restore night vision and improve the eyes ability to adjust to low-light conditions, often working alongside Vitamin A.
Limitations
- Inconclusive for Prevention.There is no strong evidence that zinc supplements prevent the initial onset of macular degeneration in healthy eyes or those with very early signs of the disease.
- Variable Genetic Response.Preliminary research suggests that individual genetic markers may influence whether zinc provides a protective benefit or potentially increases risk, though this is not yet a standard clinical guide.
- Not a Cure for Vision Loss.Zinc is used to slow future deterioration; it has not been shown to restore sight in eyes that have already reached advanced stages of disease or geographic atrophy.
Things to consider
High doses may cause gastrointestinal discomfort or increase the risk of genitourinary issues in men. Supplementing with high-dose zinc typically requires copper to prevent a zinc-induced copper deficiency.
Study evidence
39 studiesZinc-containing supplements can help slow progression of age-related macular degeneration in people at higher risk of advanced disease. This does not establish sharper vision for healthy eyes or prevention of the condition, and benefits from antioxidant combinations cannot be attributed entirely to zinc.
Astaxanthin Other Nutrients
Impact
High effect
Typical dose4–12 mg / day
Astaxanthin is a unique and potent antioxidant that can effectively reach the inner eye tissues. It helps protect against light-induced damage, improves blood flow to the retina, and has been shown in clinical studies to reduce symptoms of eye fatigue, strain, and blurred vision associated with digital screen use.
- Focuses on
- Most relevant for
- People who frequently use digital screens and experience eye fatigue or strain.
Potential benefits
- Relief from digital eye strain.Clinical studies indicate supplementation can reduce subjective symptoms of fatigue and discomfort associated with prolonged screen use.
- Support for middle-aged visual sharpness.Research suggests it may help maintain visual acuity specifically after screen-induced stress in adults aged 40 and older.
- Dry eye symptom relief.Unconfirmed. Preliminary findings suggest potential improvements in tear film stability and eye comfort, though this remains unconfirmed due to a lack of controlled comparison groups in the studies.
Limitations
- Inconsistent visual performance.Benefits do not reliably extend to baseline visual sharpness, the eyes' ability to focus, or tracking moving objects.
- Variable age-related benefits.Certain protective effects on visual acuity after screen use were observed in older adults but not in those under age 40.
- No effect on myopia progression.Systematic reviews indicate that supplementation does not consistently slow the progression of nearsightedness or axial eye elongation.
Study evidence
7 studiesAstaxanthin may reduce eye strain associated with screen use, but improvements in visual performance are uneven. The available research is more supportive of relief from visual fatigue than of consistently sharper vision, myopia control or broad protection against eye disease.
Copper Minerals
Impact
High effect
Typical dose1–2 mg / day
High-dose zinc supplementation, as recommended in the AREDS2 formula for vision support, can interfere with copper absorption and lead to a deficiency. Including a small amount of copper is not for direct vision benefits but is a crucial safety and efficacy measure to balance the zinc intake.
- Focuses on
- Most relevant for
- People using high-dose zinc supplements for age-related macular health who need to prevent mineral imbalances.
Potential benefits
- Nutritional Balance with Zinc.Prevents mineral deficiency caused by high-dose zinc supplementation, which is a standard safety measure in eye health protocols like AREDS2.
- Macular Health Association.Unconfirmed. Observational studies link higher dietary copper intake to a reduced risk of progressing to late-stage age-related macular degeneration, though this is not proven for copper supplements alone.
- Glaucoma Risk Support.Unconfirmed. Some longitudinal research indicates that higher copper intake may be associated with a lower incidence of glaucoma, though further clinical validation is required.
Limitations
- Isolated Efficacy Unknown.Copper is rarely studied as a standalone supplement for vision; its benefits are typically observed as part of multi-nutrient antioxidant formulas.
- Myopia Progression Risk.Higher blood levels of copper have been associated with increased myopia progression in children, suggesting a complex role in eye growth.
- Observational Data Constraints.Much of the supportive evidence is based on dietary intake rather than supplementation, which may reflect overall healthier eating habits.
Things to consider
Supplemental copper is primarily used to offset the copper-depleting effects of high-dose zinc and is not intended to improve visual sharpness on its own.
Study evidence
7 studiesHigher dietary copper intake is associated with lower risk of some age-related eye problems, but this does not prove that copper supplements improve vision. Benefits from multi-nutrient eye supplements cannot be assigned to copper alone, and blood-level findings are not uniformly favorable.
Studies
Explore published research for this goal.
Sources
Up to five highest-ranked published examples per ingredient. Study counts and charts include all published studies for the connection.
- Role of Oral Vitamin 'C' on Astigmatic Errors in Phacoemulsification.
- Ascorbic acid metabolites are involved in intraocular pressure control in the general population.
- Nutritional modulation of cataract.
- Dietary n-3 Fatty Acid, α-Tocopherol, Zinc, vitamin D, vitamin C, and β-carotene are Associated with Age-Related Macular Degeneration in Japan.
- Adherence to a Mediterranean diet, lifestyle and age-related macular degeneration: the Coimbra Eye Study - report 3.
- Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration.
- Dietary carotenoids, vitamins C and E, and risk of cataract in women: a prospective study.
- Long-term nutrient intake and 5-year change in nuclear lens opacities.
- Dietary intake of antioxidants and risk of age-related macular degeneration.
- Antioxidant vitamin and mineral supplements for age-related macular degeneration.
- Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.
- Oral zinc in macular degeneration.
- A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8.
- Effect of vitamin A and zinc supplementation on the nutriture of children in Northeast Thailand.
- Benefits and Safety of Astaxanthin in the Treatment of Mild-To-Moderate Dry Eye Disease.
- Astaxanthin (AstaReal®) Improved Acute and Chronic Digital Eye Strain in Children: A Randomized Double-Blind Placebo-Controlled Trial.
- Effects of diet containing astaxanthin on visual function in healthy individuals: a randomized, double-blind, placebo-controlled, parallel study.
- Astaxanthin, cell membrane nutrient with diverse clinical benefits and anti-aging potential.
- Nutritional Supplementation for Myopia Prevention and Control: A Systematic Review of Randomized Controlled Trials.
- What did we learn in 35 years of research on nutrition and supplements for age-related macular degeneration: a systematic review.
- Dietary Nutrient Intake and Progression to Late Age-Related Macular Degeneration in the Age-Related Eye Disease Studies 1 and 2.
- Association between late age-related macular degeneration and dietary intake of copper, iron, zinc and selenium: a 2005-2008 NHANES cross-sectional observational study.
- Associations between dietary nutrient intake and the risk of multiple age-related ocular diseases: evidence from longitudinal analysis.
- Dietary habits and dietary nutrient intake in patients with age-related macular degeneration: A case-control study.
- Dietary omega-3 LCPUFA intake in the prevention of neovascular age-related macular degeneration: a systematic review and meta-analysis.
- Dietary omega-3 polyunsaturated fatty acids and fish intake and risk of age-related macular degeneration.
- Dietary fatty acid intake, plasma fatty acid levels, and the risk of age-related macular degeneration (AMD): a dose-response meta-analysis of prospective cohort studies.
- Dietary ω-3 fatty acid and fish intake and incident age-related macular degeneration in women.
- Can Omega-3 Fatty Acids Serve as a Preventive Strategy for Age-Related Macular Degeneration? A Systematic Review and Meta-Analysis.
- A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa.
- Efficacy and safety of retinol palmitate ophthalmic solution in the treatment of dry eye: a Japanese Phase II clinical trial.
- Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age.
- Vitamin A supplementation improves retinal function in infants at risk of retinopathy of prematurity.
- Effect of short-term, high-dose retinol on dark adaptation in aging and early age-related maculopathy.
- Dietary flavonoids and the prevalence and 15-y incidence of age-related macular degeneration.
- The effect of flavonoids on visual function in patients with glaucoma or ocular hypertension: a systematic review and meta-analysis.
- Dietary flavonoids are associated with longitudinal treatment outcomes in neovascular age-related macular degeneration.
- Dietary Flavonoid Intake and Chronic Sensory Conditions: A Scoping Review.
- Effects of Flavonoid Supplementation on Common Eye Disorders: A Systematic Review and Meta-Analysis of Clinical Trials
- The Associations of Plasma Carotenoids and Vitamins With Risk of Age-Related Macular Degeneration: Results From a Matched Case-Control Study in China and Meta-Analysis.
- Serum carotenoids and risk of age-related macular degeneration in a chinese population sample.
- Serum antioxidants and age-related macular degeneration in a population-based case-control study.
- Association between serum carotenoid concentrations and risk of major age-related eye diseases among middle-aged and older adults.
- Plasma antioxidant vitamins and carotenoids and age-related cataract
- One-year outcomes of resveratrol supplement with aflibercept versus aflibercept monotherapy in wet age-related macular degeneration.
- Resveratrol Supplementation in Wet AMD: Association With Fewer Intravitreal Injections and Reduced Macular Fibrosis.
- Efficacy and safety of vitamin supplements with resveratrol in diabetic macular edema: Long-term results of a comparative study
- Effect of Resveratrol-Based Nutritional Supplement on Choroidal Thickness: A Pilot Study
- U.S. Multicenter Clinical Trial of Corneal Collagen Crosslinking for Treatment of Corneal Ectasia after Refractive Surgery.
- United States Multicenter Clinical Trial of Corneal Collagen Crosslinking for Keratoconus Treatment.
- EpiSmart Crosslinking for Keratoconus: A Phase 2 Study.
- Prospective Randomized Trial of Corneal Cross-linking Riboflavin Dosing Frequencies for Treatment of Keratoconus and Corneal Ectasia.
- Corneal collagen cross-linking for keratoconus: results of 3-year follow-up in Pakistani population.
- A randomized, double-masked study on the treatment of retinal vein occlusion with troxerutin
- Efficacy and safety of AZR-MD-001 selenium sulfide ophthalmic ointment in adults with meibomian gland dysfunction: A vehicle-controlled, randomized clinical trial.
- The efficacy and safety of selenium supplementation versus placebo in the treatment of Graves' orbitopathy: A systematic review and meta-analysis of randomised controlled trials.
- Efficacy and safety of AZR-MD-001 selenium sulfide ophthalmic ointment in adults with meibomian gland dysfunction over six months of treatment: A Phase 2, vehicle-controlled, randomized extension trial.
- AZR-MD-001 0.5% selenium sulfide ophthalmic ointment for the treatment of contact lens discomfort: A vehicle-controlled, randomized, clinical trial.
- The effect of a biweekly novel selenium sulfide-containing topical treatment in symptomatic contact lens wearers: An exploratory study.
- Associations Between Vitamin D Intake and Progression to Incident Advanced Age-Related Macular Degeneration.
- Circulating vitamin D concentration and age-related macular degeneration: Systematic review and meta-analysis.
- Low serum vitamin D is associated with axial length and risk of myopia in young children.
- The effect of vitamin D supplementation on the outcome of treatment with bevacizumab in diabetic macular edema: a randomized clinical trial.
- Vitamin D Deficiency and Dry Eye Disease: A Retrospective Cohort Study.
- Effect of Ginkgo biloba extracts in the prevention of posterior capsule opacification after cataract surgery: A randomized clinical trial.
- Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma.
- [Ginkgo extract in impaired vision--treatment with special extract EGb 761 of impaired vision due to dry senile macular degeneration].
- Short-term effects of Ginkgo biloba extract on peripapillary retinal blood flow in normal tension glaucoma.
- [The course of color vision in early diabetic retinopathy treated with Ginkgo biloba extract. A preliminary double-blind versus placebo study].
- Effects of taurine supplementation on VDT work induced visual stress.
- [Effect of vasoactive agents on visual functions and ocular blood flow in patients with early manifestations of age-related macular degeneration].